
The NHS' phased rollout of Mounjaro (tirzepatide) began in June 2025

A study of 460,000 adults prescribed GLP-1 medications showed that nearly one in five developed health issues without knowing

The TikToker was taking retatrutide, a GLP-1 medication not currently licensed for use

It's said to be three times as effective as its famous predecessors